Results 11 to 20 of about 141,920 (316)

Regression of Graft Steatosis After Liver Transplantation.

, 2022
Introduction: Liver grafts with limited steatosis are currently used for liver transplantation, but the natural history of graft steatosis is not well known. Project Aims or Questions: This program evaluation aimed at assessing changes of steatosis after
Staufer, Katharina, Banz, Vanessa, Maurer, M.H., Berzigotti, A., Berzigotti, Annalisa, Staufer, K., Maurer, Martin H, Meyer, H., Meyer, Helene, Banz, V.   +9 more
core   +1 more source

Factors Associated With Liver Steatosis in People With Human Immunodeficiency Virus on Contemporary Antiretroviral Therapy. [PDF]

, 2022
Background Given the impact of new antiretroviral drugs on weight and metabolic parameters, their potential contribution to the development of liver steatosis is of concern.
Swiss HIV Cohort Study, Berzigotti, Annalisa, Günthard, Huldrych F, Riebensahm, Carlotta, Furrer, Hansjakob, Tarr, Philip E; https://orcid.org/, Tarr, Philip E, Rauch, Andri, Wandeler, Gilles, Surial, Bernard   +9 more
core   +1 more source

Insulin sensitisers in the treatment of non-alcoholic fatty liver disease : a systematic review [PDF]

, 2011
Non-alcoholic fatty liver disease (NAFLD) is closely linked with obesity and the prevalence of NAFLD is about 17% to 33% in the Western world. There is a strong association of NAFLD with insulin resistance and, hence, insulin sensitisers have been tried.
C Clar, Henderson, R., Gurung, T., N Waugh, N Sattar, N Ghouri, Clar, C., Sattar, Naveed, Sattar, N., Fraser, A., T Gurung, Gurung, T. (Tara), D Shyangdan, A Fraser, Shyangdan, D., D Preiss, Waugh, Norman, Shyangdan, D. (Deepson), R Henderson, Ghouri, N., Preiss, D., Waugh, N.   +21 more
core   +1 more source

Controlled Attenuation Parameter reflects steatosis in compensated advanced chronic liver disease. [PDF]

, 2020
BACKGROUND & AIMS Controlled Attenuation Parameter (CAP) for steatosis assessment has not been validated in compensated advanced chronic liver disease cACLD.
Rosangela Piccinni, Nasser Semmo, Annalisa Berzigotti, Giuseppe Murgia, De Gottardi, Andrea, Susana G. Rodrigues, Matteo Montani, Stefania Casu, Murgia, Giuseppe, Dufour, Jean-François, Montani, Matteo, G. Rodrigues, Susana, Casu, Stefania, Berzigotti, Annalisa, Guido Stirnimann, Semmo, Nasser, Piccinni, Rosangela, Andrea De Gottardi, Stirnimann, Guido, Delgado, Maria G., Maria G. Delgado, Jean‐François Dufour   +21 more
core   +1 more source

Knowing what’s out there: awareness of Non Alcoholic Fatty Liver Disease.

Frontiers in Medicine, 2014
Background: Non Alcoholic Fatty Liver Disease (NAFLD) is the most common hepatic disorder, which poses a significant health burden in the western countries. As the epidemic of obesity slides health downward, the incidence of NAFLD is evidently increasing.
Vishal eGhevariya, Nan eSandar, Kishor ePatel, Nehal eGhevariya, Ruchit eShah, Joshua eAron, Sury eAnand   +6 more
doaj   +1 more source

Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis [PDF]

Clinical and Molecular Hepatology, 2021
Background/Aims Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease (NAFLD) characterized by hepatic steatosis, inflammation, hepatocellular injury, and fibrosis.
Gang Xu, Yu-Min Wang, Miao-Miao Ying, Sui-Dan Chen, Zong-Rui Li, Hong-Lei Ma, Ming-Hua Zheng, Jian Wu, Chunming Ding   +8 more
doaj   +1 more source

Resveratrol and liver: A systematic review

Journal of Research in Medical Sciences, 2015
Background: Recent studies demonstrated that resveratrol has many therapeutic effects on liver disorders. Resveratrol significantly increased survival after liver transplantation, decreased fat deposition, necrosis, and apoptosis which induced by ...
Forouzan Faghihzadeh, Azita Hekmatdoost, Payman Adibi   +2 more
doaj   +1 more source

Methaemoglobinaemia Can Complicate Normothermic Machine Perfusion of Human Livers

Frontiers in Surgery, 2021
Background: Although liver normothermic machine perfusion is increasingly used clinically, there are few reports of complications or adverse events. Many centers perform liver NMP to viability test suboptimal grafts, often for prolonged periods.
Samuel J. Tingle, Samuel J. Tingle, Ibrahim Ibrahim, Ibrahim Ibrahim, Emily R. Thompson, Emily R. Thompson, Lucy Bates, Lucy Bates, Ashwin Sivaharan, Yvonne Bury, Yvonne Bury, Rodrigo Figuereido, Rodrigo Figuereido, Colin Wilson   +13 more
doaj   +1 more source

Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data [PDF]

, 2012
Background Liver biopsy is considered as the gold standard for assessing non-alcoholic fatty liver disease (NAFLD) histologic lesions in patients with severe obesity.
Mathurin, Philippe, Karine Clement (2245), Poynard, Thierry, Charlotte, Frederic, Guillaume Lassailly, Emmanuel Diaz, Philippe Mathurin (177542), Caıazzo, Robert, Demol, Bernard, Tordjman, Joan, Guillaume Lassailly (177527), François Pattou, Pierre Bedossa, Perazzo Hugo, Vlad Ratziu (38088), Robert Callafe (177536), Bedossa, Pierre, Ratziu, Vlad, Clement Karine, Charlotte Frederic, Munteanu Mona, Bernard Demol (177533), Pattou, François, FLIP consortium, Frederic Charlotte (43075), Pierre Bedossa (48266), Emmanuel Diaz (177528), Thierry Poynard (38084), Lassailly, Guillaume, Joan Tordjman (48258), Lassailly Guillaume, Bernard Demol, Mathurin Philippe, Tordjman Joan, Frederic Charlotte, Clement, Karine, Karine Clement, Joan Tordjman, Robert Caïazzo (177530), Perazzo, Hugo, Mona Munteanu (38097), Bedossa Pierre, Philippe Mathurin, Ratziu Vlad, Thierry Poynard, Mona Munteanu, Callafe Robert, Pattou François, Robert Caïazzo, Diaz Emmanuel, Hugo Perazzo (143739), Demol Bernard, Caïazzo Robert, Callafe, Robert, Munteanu, Mona, Diaz, Emmanuel, Hugo Perazzo, Robert Callafe, Vlad Ratziu, François Pattou (145757), Poynard Thierry   +60 more
core   +1 more source

Adipokines and redox signaling: impact on fatty liver disease. [PDF]

, 2011
Adipokines (adipose tissue cytokines) are polypeptide factors secreted by adipose tissue in a highly regulated manner. The 'classical' adipokines (leptin, adiponectin, and resistin) are expressed only by adipocytes, but other adipokines have been shown ...
Marra, Fabio., Parola, Maurizio, Parola, Maurizio.   +2 more
core   +1 more source